What's new

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 26, Status: Authorised

Apr 11, 2025 - 09:45
 0
Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

C&W Market Beat 2024 – Hotel Investment In Europe

Next Article

Hyatt Place Ha Long Bay Bai Chay Debuts as The First Hyatt Place Branded Hotel i...

Related Posts

Minutes of the PRAC meeting 13-16 May 2024

Apr 9, 2025  0

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): VidPrevtyn Beta, SARS-CoV2 prefusion Spike delta TM (CoV-2 preS dTM) adjuvanted with AS03, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Vaccines, PIP number: P/0072/2024

Opinion/decision on a Paediatric investigation plan (PI...

Apr 14, 2025  0